411-420 of 2924 results
Construction project risk-management strategies in a challenging market
Disputes will always be a key risk to be managed on major projects. Now, though, principals and contractors must also grapple with decades-high inflation rates and the ongoing impacts of the COVID-19 pandemic and the Ukraine war. ...
Strengthening the regulation of Buy Now Pay Later (BNPL) in Australia
As expected, increased regulation of the Buy Now Pay Later (BNPL) industry is becoming more likely following Treasury's release of the options paper, Regulating Buy Now, Pay Later in Australia (Options Paper). ...
ASIC v CBA: s912A does not require perfection
In this Insight, we examine the court's interpretation of the s912A obligation and provide guidance on mitigating misleading and deceptive conduct risk for AFS licenses. ...
CDR action initiation is coming – what does it mean and why does it matter?
On 26 September 2022, the Treasury released draft legislation to enable action initiation under the national Consumer Data Right ( CDR ) regime ( AI Exposure Draft ). One month later, on 30 Novembe ...
Best practice ESG due diligence for energy investments
This Insight explores proven ways dealmakers can close energy deals efficiently, while maximising value creation and managing ESG risks. ...
Financial services regulatory update
Webinar: Financial services regulatory update: Secret commission offence provisions for SFTs; derivatives regulation and ASIC's Reportable Situations Regime ...
WA Government announces changes to Market-led Proposal policy
The Western Australian Government has announced changes to its Market-led Proposals (MLP) policy to improve timeframes, accountability and expectations surrounding the policy and lead agencies. ...
Planning for fair winds ahead: key risks for disputes in the Australian offshore wind industry
In this Insight, we outline some of the key risks which might give rise to disputes and how those risks can best be managed as Australia aims for fair winds ahead. ...
Patenting clinical stage inventions: beware of clinical trial disclosures
Publicly available clinical trial information can form part of the prior art base and pose a significant risk to a patent or patent application. ...
Diversity and inclusion in the boardroom and beyond
Diversity and inclusion (D&I) continues to be an important ESG consideration for companies. In this Insight, we cover some of the key Australian and international D&I-related legal, regulatory and commercial developments. ...